Your browser doesn't support javascript.
loading
Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease?
Mert, Ismail; Kumar, Amanika; Torres, Diogo; Huang, Yajue; McGree, Michaela E; Weaver, Amy L; Cliby, William A.
Affiliation
  • Mert I; Division of Gynecologic Oncology, Mayo Clinic, Rochester, United States of America. Electronic address: mert.ismail@mayo.edu.
  • Kumar A; Division of Gynecologic Oncology, Mayo Clinic, Rochester, United States of America.
  • Torres D; Division of Gynecologic Oncology, Mayo Clinic, Rochester, United States of America.
  • Huang Y; Division of Pathology, Mayo Clinic, Rochester, United States of America.
  • McGree ME; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States of America.
  • Weaver AL; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States of America.
  • Cliby WA; Division of Gynecologic Oncology, Mayo Clinic, Rochester, United States of America.
Gynecol Oncol ; 153(2): 238-241, 2019 05.
Article in En | MEDLINE | ID: mdl-30833135

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cytoreduction Surgical Procedures / Carcinoma, Ovarian Epithelial / Intestinal Mucosa Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2019 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cytoreduction Surgical Procedures / Carcinoma, Ovarian Epithelial / Intestinal Mucosa Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2019 Document type: Article Country of publication: